MEG3 and type 2 diabetes mellitus: Additionally, in HepG2 cells, the authors observed that elevated MEG3 expression aggravated palmitate-induced IR by regulating the miR-185-5p/EGR2 axis, suggesting that MEG3 may be a useful target in new therapeutic strategies for T2D (Figure 3) [74].